What Are The Socioeconomic Impacts Of Life-Span-Extending Medicines And Treatments? What Developments Are Really Promising?

Source: Life Science Leader
David_Pyott LN

A | THERE WILL BE CONVERGENCE OF MEDICAL DEVICES AND LARGE AND SMALL MOLECULES enabling better bioavailability for patients. One example is Rani Therapeutics’ technology where a pill is swallowed and a needle containing a drug in the lumen is deployed and injected directly into the stomach wall. Another is Proteus Digital Health’s technology that provides an e-monitoring record of patient compliance to physician and patient. Convergence of mobile technology and AI with interconnected devices will enable the migration of patients from the ICU to the general ward to homecare as compressed data on vital signs and their diagnostic interpretation are available in real time.

DAVID PYOTT is the chairman of Bioniz Therapeutics, a small startup in Irvine, CA. The former CEO of Allergan also serves the corporate boards of Avery Dennison, Alnylam Pharmaceuticals, BioMarin Pharmaceutical, and Royal Philip.